Analyst Ratings for Summit Therapeutics plc (SMMT)
SMMT Rating Summary
SMMT Price Target Summary
- Highest: $44.00 (H.C. Wainwright)
- Lowest: $23.00 (Citi)
- Average: $34.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$34.00 (+83.4%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 76%
Avg. $ Target:
$34.00 (+83.4%)
* Over Last 12-Mos
Rating Score: 7 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/6/2024 | Jefferies | Hangfei Fu | New Coverage | Buy (N/A) |
31.00 (N/A) |
17.52 (18.54) |
5.82% | Details |
| 11/4/2024 | JMP Securities | Reni Benjamin | New Coverage | Market Outperform (N/A) |
32.00 (N/A) |
18.59 (18.54) |
-0.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
